Poly Medicure Ltd

Poly Medicure Ltd

Poly Medicure Ltd has rescheduled its investor/analyst meet from August 20th to August 27th, 2026.

Poly Medicure Ltd

Poly Medicure Ltd has announced a schedule of investor meetings with analysts and investors on August 27th and 31st, 2026.

Poly Medicure Ltd

Poly Medicure Ltd has cancelled its investor meet scheduled for 20 August 2026 due to exigencies.

Poly Medicure Ltd

Poly Medicure Ltd has announced a schedule for one-on-one meetings with analysts/investors on August 20, 2026, to discuss unpublished price sensitive information. The meetings are subject to change due to exigencies.

Poly Medicure Ltd

Poly Medicure Ltd has published a newspaper advertisement regarding its upcoming Annual General Meeting (AGM) to be held on September 05, 2026, through video conferencing.

Poly Medicure Ltd

Poly Medicure Ltd's Q1 FY27 earnings call highlights the company's strategic vision for FY2030, PolyMed 3.0, aiming to double revenue by FY30 through organic and inorganic expansion, leveraging technology, and deepening customer access in international markets. The company reports a 12.3% growth in standalone revenue to INR431 crores, with a 16.2% growth in domestic revenue and 10% growth in international revenue. Gross profit margin improved to 71.5%, and EBITDA margin exceeded the guided range at 28%.

Poly Medicure Ltd

Poly Medicure Ltd has announced its 31st Annual General Meeting (AGM) and Annual Report for the Financial Year ended March 31, 2026, to be held on September 5, 2026.

Poly Medicure Ltd

Poly Medicure Ltd has announced a record date for the purpose of final dividend for the FY 2025-26. The record date is August 29, 2026, and the dividend is 3.50 per equity share on the face value of 5 per share. The dividend will be paid if approved at the upcoming Annual General Meeting on September 5, 2026.

Poly Medicure Ltd

Poly Medicure Ltd has announced a record date and book closure for the purpose of final dividend for FY 2025-26, with a dividend of 3.50 per equity share on the face value of 5 per share.

Poly Medicure Ltd

Poly Medicure Ltd has announced a book closure for the purpose of record date for the final dividend for FY 2025-26, with a record date of August 29, 2026, and a dividend of 3.50 per equity share.

Poly Medicure Ltd

Poly Medicure Ltd has announced the dispatch of a letter to shareholders whose email addresses are not registered with the company or depositories, providing a web link to access the annual report for FY 2025-26 and the notice of the 31st AGM to be held on September 5, 2026. The company also requests shareholders to update their PAN, KYC, and bank details with the RTA.

Poly Medicure Ltd

Poly Medicure Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, as per SEBI regulations.

Poly Medicure Ltd

Poly Medicure Ltd has announced its 31st Annual General Meeting to be held on September 05, 2026, through Video Conferencing or Other Audio-Visual Means. The meeting will consider and adopt the audited standalone financial statements for the year ended March 31, 2026, and other business.

Poly Medicure Ltd

Poly Medicure Ltd has made the audio recording of its earnings conference call for the quarter ended June 30, 2026, available on its website.

Poly Medicure Ltd

Poly Medicure Ltd has submitted a statement of deviation or variation for the quarter ended June 30, 2026, regarding the utilization of funds raised through Qualified Institutions Placement (QIP). The company has reviewed the actual utilization of funds received for an amount aggregating Rs 99,999.98 lakh, which is in line with the objects of the issue. There is no deviation or variation from the objects of the issue in the utilization of proceeds.

Poly Medicure Ltd

Poly Medicure Limited submitted the Monitoring Agency Report for the quarter ended June 30, 2026, as per Regulation 173A of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Poly Medicure Ltd

Poly Medicure Ltd has published unaudited financial results for the quarter ended June 30, 2026, in newspapers Financial Express and Jansatta, as per Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Poly Medicure Ltd

Poly Medicure Ltd has submitted its unaudited financial results for the first quarter ended June 30, 2026, as part of its investor presentation.

Poly Medicure Ltd

Poly Medicure Ltd informed about the resignation of Mr. Ravi Prakash as Deputy Company Secretary and Compliance Officer, and the company's unaudited financial results for the quarter ended June 30, 2026, which show revenue of Rs. 45,974.91 lakhs and net profit of Rs. 18,123.85 lakhs.

Poly Medicure Ltd

Poly Medicure Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has also granted 1,476 ESOP options to employees under the ESOP Scheme, 2020, and allotted 1,975 equity shares to eligible employees. The company has also re-appointed Jai Prakash & Company as the cost auditors for the financial year 2026-27 and announced the resignation of Deputy Company Secretary, KMP, Mr. Ravi Prakash.